1-8 of 8
kidney
Close
Sort by
Journal Articles

Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis

Clinical Trials & Observations
Andrew Staron, Eric J. Burks, John C. Lee, Shayna Sarosiek, J. Mark Sloan, Vaishali Sanchorawala
Journal: Blood Advances
Blood Adv (2020) 4 (5): 880–884.
https://doi.org/10.1182/bloodadvances.2019001331
Published: 2020
Journal Articles

Organ responses with daratumumab therapy in previously treated AL amyloidosis

Clinical Trials & Observations
Alfred Chung, Gregory P. Kaufman, Surbhi Sidana, Erik Eckhert, Stanley L. Schrier, Richard A. Lafayette, Sally Arai, Ronald M. Witteles, Michaela Liedtke
Journal: Blood Advances
Blood Adv (2020) 4 (3): 458–466.
https://doi.org/10.1182/bloodadvances.2019000776
Published: 2020
Journal Articles

Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone

Efstathios Kastritis, Ioanna Dialoupi, Maria Gavriatopoulou, Maria Roussou, Nikolaos Kanellias, Despina Fotiou, Ioannis Ntanasis-Stathopoulos, Elektra Papadopoulou, Dimitrios C. Ziogas, Kimon Stamatelopoulos, Efstathios Manios, Argyrios Ntalianis, Evangelos Eleutherakis-Papaiakovou, Asimina Papanikolaou, Magdalini Migkou, Aristea-Maria Papanota, Harikleia Gakiopoulou, Erasmia Psimenou, Maria Irini Tselegkidi, Ourania Tsitsilonis, Ioannis Kostopoulos, Evangelos Terpos, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3002–3009.
https://doi.org/10.1182/bloodadvances.2019000147
Published: 2019
Includes: Supplemental data
Journal Articles

Pathophysiology and management of monoclonal gammopathy of renal significance

Clinical Trials & Observations
Ankur Jain, Richard Haynes, Jaimal Kothari, Akhil Khera, Maria Soares, Karthik Ramasamy
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2409–2423.
https://doi.org/10.1182/bloodadvances.2019031914
Published: 2019
Includes: Supplemental data
Journal Articles

Elimination of the fibrinogen integrin α M β 2 -binding motif improves renal pathology in mice with sickle cell anemia

Md Nasimuzzaman, Paritha I. Arumugam, Eric S. Mullins, Jeanne M. James, Katherine VandenHeuvel, Marilou G. Narciso, Maureen A. Shaw, Sarah McGraw, Bruce J. Aronow, Punam Malik
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1519–1532.
https://doi.org/10.1182/bloodadvances.2019032342
Published: 2019
Includes: Supplemental data
Journal Articles

Hyperfiltration predicts long-term renal outcomes in humanized sickle cell mice

Malgorzata Kasztan, Brandon M. Fox, Jeffrey D. Lebensburger, Kelly A. Hyndman, Joshua S. Speed, Jennifer S. Pollock, David M. Pollock
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1460–1475.
https://doi.org/10.1182/bloodadvances.2018028878
Published: 2019
Journal Articles

Standard measures for sickle cell disease research: the PhenX Toolkit sickle cell disease collections

James R. Eckman, Kathryn L. Hassell, Wayne Huggins, Ellen M. Werner, Elizabeth S. Klings, Robert J. Adams, Julie A. Panepinto, Carol M. Hamilton
Journal: Blood Advances
Blood Adv (2017) 1 (27): 2703–2711.
https://doi.org/10.1182/bloodadvances.2017010702
Published: 2017
Journal Articles

Cardiac and renal complications of carfilzomib in patients with multiple myeloma

Meletios A. Dimopoulos, Maria Roussou, Maria Gavriatopoulou, Erasmia Psimenou, Dimitrios Ziogas, Evangelos Eleutherakis-Papaiakovou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Ioannis Panagiotidis, Argyrios Ntalianis, Elektra Papadopoulou, Kimon Stamatelopoulos, Efstathios Manios, Constantinos Pamboukas, Sofoklis Kontogiannis, Evangelos Terpos, Efstathios Kastritis
Journal: Blood Advances
Blood Adv (2017) 1 (7): 449–454.
https://doi.org/10.1182/bloodadvances.2016003269
Published: 2017